| Product Code: ETC12463391 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Pakistan Imatinib Drug Market Overview |
3.1 Pakistan Country Macro Economic Indicators |
3.2 Pakistan Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Pakistan Imatinib Drug Market - Industry Life Cycle |
3.4 Pakistan Imatinib Drug Market - Porter's Five Forces |
3.5 Pakistan Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Pakistan Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Pakistan Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Pakistan Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Pakistan Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Pakistan Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Pakistan |
4.2.2 Growing awareness about the effectiveness of imatinib in treating CML |
4.2.3 Favorable government regulations supporting the availability and affordability of imatinib |
4.3 Market Restraints |
4.3.1 High cost of imatinib therapy leading to affordability issues for patients |
4.3.2 Presence of generic alternatives impacting the market share of branded imatinib |
4.3.3 Limited healthcare infrastructure and access to specialized care in certain regions of Pakistan |
5 Pakistan Imatinib Drug Market Trends |
6 Pakistan Imatinib Drug Market, By Types |
6.1 Pakistan Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Pakistan Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Pakistan Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Pakistan Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Pakistan Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Pakistan Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Pakistan Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Pakistan Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Pakistan Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Pakistan Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Pakistan Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Pakistan Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Pakistan Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Pakistan Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Pakistan Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Pakistan Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Pakistan Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Pakistan Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Pakistan Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Pakistan Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Pakistan Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Pakistan Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Pakistan Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Pakistan Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Pakistan Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Pakistan Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Pakistan Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Pakistan Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Pakistan Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Pakistan Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Pakistan Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Pakistan Imatinib Drug Market Import-Export Trade Statistics |
7.1 Pakistan Imatinib Drug Market Export to Major Countries |
7.2 Pakistan Imatinib Drug Market Imports from Major Countries |
8 Pakistan Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare facilities offering imatinib treatment |
8.3 Rate of early diagnosis of CML in Pakistan |
8.4 Availability of patient assistance programs for imatinib therapy |
8.5 Number of clinical trials and research initiatives focused on imatinib in Pakistan |
9 Pakistan Imatinib Drug Market - Opportunity Assessment |
9.1 Pakistan Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Pakistan Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Pakistan Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Pakistan Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Pakistan Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Pakistan Imatinib Drug Market - Competitive Landscape |
10.1 Pakistan Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Pakistan Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here